{"id":"W1989740966","doi":"10.1111/j.1365-2141.2008.07573.x","title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology","keywords":"Medicine; Bortezomib; Peripheral neuropathy; Multiple myeloma; Internal medicine; Guideline; Surgery; Gastroenterology; Oncology; Diabetes mellitus; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001264354,0.0001449552,0.0010151,0.0002742991,0.00003086951,0.00001097399,0.0002074832,0.00009528508,0.00004432715],"category_scores_gemma":[0.001317771,0.0001011942,0.0002269121,0.0003950353,0.0001555007,0.000112275,0.00001382092,0.0003897841,5.830128e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001331685,"about_ca_system_score_gemma":0.0004162421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006220032,"about_ca_topic_score_gemma":0.0002616167,"domain_scores_codex":[0.9970384,0.0005700606,0.001481912,0.0001839256,0.0004388972,0.0002868437],"domain_scores_gemma":[0.9982498,0.0002681076,0.0007303227,0.000282698,0.0003524023,0.000116687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.525521,0.02940449,0.1960249,0.0005045694,0.0007714494,0.1196104,0.00362699,0.0004461785,0.01794455,0.00006209905,0.001974946,0.1041084],"study_design_scores_gemma":[0.3818423,0.01497316,0.5334686,0.0008189531,0.0001531604,0.06270134,0.0004882791,0.004678361,0.0005592283,0.0001726658,0.00001023296,0.0001337247],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976618,0.0005980214,0.0001281397,0.0004492089,0.00003545969,0.001038281,0.00001796996,0.000004569455,0.00006652959],"genre_scores_gemma":[0.9986946,0.0001046263,0.001057588,0.00005525097,0.00004187535,0.000009117995,0.0000214159,0.000009861143,0.000005648472],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3374436,"threshold_uncertainty_score":0.4126581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03042436538693536,"score_gpt":0.361632983993509,"score_spread":0.3312086186065736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}